Business Context and Reporting Period
This Form 8-K Current Report was filed by Pavmed Inc. on February 22, 2022. The filing primarily addresses the appointment of Shaun O'Neil as Chief Operating Officer and the execution of a new employment agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and corporate governance rather than financial performance.
Material Changes
The material change reported is the elevation of Shaun O'Neil from Chief Commercial Officer and Executive Vice President of Business Development to Chief Operating Officer. This change is accompanied by a new employment contract and equity grant.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, market outlook, or discussion of risks and contingencies. Management commentary is limited to the details of the executive appointment and the terms of the associated employment agreement.
Employment Agreement Terms
- Role: Chief Operating Officer.
- Term: Initial term expires February 22, 2025, with automatic one-year renewals unless notice is given.
- Base Salary: $325,000 annually.
- Performance Bonus: Up to 50% of base salary, contingent on meeting objectives.
- Equity Grant: 300,000 stock options with an exercise price of $1.48 per share. Vesting occurs quarterly over 12 months starting March 31, 2022.
- Termination Benefits: In the event of termination without cause or resignation with good reason, the executive is entitled to 12 months of base salary, pro-rata bonus, and health insurance coverage.
- Restrictions: Includes non-compete provisions for one year post-employment (two years in case of a change of control).
Important Facts for Investor Verification
- Verify the impact of the new COO appointment on the company's commercial strategy and operational execution.
- Review the dilution impact of the 300,000 stock options granted at $1.48 per share.
- Confirm the total potential cash compensation liability ($325,000 base + up to $162,500 bonus) and the 12-month severance obligation.
- Check the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "cause" and "good reason."